Literature DB >> 4363235

Mutation in Shigella flexneri resulting in loss of ability to penetrate HeLa cells and loss of glycerol kinase activity.

R Kim, L M Corwin.   

Abstract

A colonial variant of a virulent Shigella flexneri 2a has lost both virulence and glycerol kinase activity. It also has several other altered characteristics: lowered ability to oxidize tricarboxylic acid cycle intermediates, increased electrophoretic mobility, and decreased sensitivity to sodium lauryl sulfate. Genetic analysis has revealed that the gene governing glycerol kinase activity in Shigella has a different chromosomal locus than that from Escherichia coli. Furthermore, transduction of the Shigella glycerol kinase gene (glp K) into the avirulent Shigella strain can restore the ability to penetrate HeLa cells, whereas the gene from E. coli cannot. About half of the glp K mutants lose this ability, and only about half of the revertants of an avirulent glp K mutant regain it. This indicates that more than one gene affects glycerol kinase activity in Shigella, only one of which is associated with penetration. Glycerol kinase activity is closely correlated with changes in electrophoretic mobility, but does not appear to have any relationship to sodium lauryl sulfate sensitivity nor to the oxidation of tricarboxylic acid cycle intermediates.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4363235      PMCID: PMC414906          DOI: 10.1128/iai.9.5.916-923.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Selecting bacterial mutants by the penicillin method.

Authors:  L GORINI; H KAUFMAN
Journal:  Science       Date:  1960-02-26       Impact factor: 47.728

2.  The use of the guinea-pig conjunctivae as an experimental model for the study of virulence of Shigella organisms.

Authors:  D C MACKEL; L F LANGLEY; L A VENICE
Journal:  Am J Hyg       Date:  1961-03

3.  In-vitro interaction of Shigella flexneri with leukocytes and HeLa cells.

Authors:  O Calabi
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

Review 4.  Current linkage map of Escherichia coli.

Authors:  A L Taylor
Journal:  Bacteriol Rev       Date:  1970-06

5.  Protection of Monkeys Against Experimental Shigellosis with Attenuated Vaccines.

Authors:  S B Formal; E H Labrec; A Palmer; S Falkow
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

6.  Genetic determination of resistance to acriflavine, phenethyl alcohol, and sodium dodecyl sulfate in Escherichia coli.

Authors:  H Nakamura
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

7.  Factors affecting virulence of Shigella flexneri: avirulent strain with altered metablism of succinate, fumarate, and malate.

Authors:  R Kim; L M Corwin
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

8.  Mechanisms and genetics of resistance to sodium lauryl sulfate in strains of Shigella and Escherichia coli.

Authors:  L M Corwin; S W Rothman; R Kim; L A Talevi
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

9.  CHARACTERIZATION OF AN HFR STRAIN OF SHIGELLA FLEXNERI.

Authors:  H SCHNEIDER; S FALKOW
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

10.  Glycerol-specific revertants of a phosphoenolpyruvate phosphotransferase mutant: suppression by the desensitization of glycerol kinase to feedback inhibition.

Authors:  M Berman; E C Lin
Journal:  J Bacteriol       Date:  1971-01       Impact factor: 3.490

View more
  3 in total

Review 1.  Genetic basis of virulence in Shigella species.

Authors:  T L Hale
Journal:  Microbiol Rev       Date:  1991-06

2.  Molecular analysis of the glpFKX regions of Escherichia coli and Shigella flexneri.

Authors:  V Truniger; W Boos; G Sweet
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

3.  Spontaneous insertion of an IS1-like element into the virF gene is responsible for avirulence in opaque colonial variants of Shigella flexneri 2a.

Authors:  J A Mills; M M Venkatesan; L S Baron; J M Buysse
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.